NCT05916586View on ClinicalTrials.gov

Effect of Short-term Prednisone Therapy on C-reactive Protein in Patients With Acute Heart Failure

NACompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

August 11, 2023

Primary Completion Date

April 21, 2024

Study Completion Date

July 8, 2024

Conditions

Acute Heart Failure

Interventions

DRUG

Prednisone

Prednisone 40 mg orally once a day for 7 days

Trial Locations (3)

Unknown

"Armenia Republican Medical Center", Yerevan

"Mikaelyan Surgery Institute", Yerevan

Erebouni Medical Center, Yerevan

Sponsors

Lead Sponsor

Heart Initiative

All Listed Sponsors

lead

Heart Initiative

OTHER

NCT05916586 - Effect of Short-term Prednisone Therapy on C-reactive Protein in Patients With Acute Heart Failure | Biotech Hunter | Biotech Hunter